Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
Filter By
Select Practice Area
-
See More$100 Million Settlement – Chase Bank USA, N.A. “Check Loan” Contract Litigation
In re Chase Bank USA, N.A. “Check Loan” Contract Litig., No. 09-2032 (N.D. Cal.)Milberg served on the Executive Committee representing the class in this action against JP Morgan Chase & Co. The complaint alleged that Chase improperly increased by 150% the minimum monthly payment required for customers who entered into balance transfer loans with “fixed” interest rates that were guaranteed to remain so for the “life of the loan.” Milberg and its Co-Counsel achieved a $100 million settlement for the class. -
See More$29.5+ Million Settlement – Dealer Management Systems Antitrust Litigation
Management Systems Antitrust Litigation, MDL 2817 (U.S. District Court for the Northern District of Illinois)Milberg is appointed Lead Counsel in this nationwide class action representing car dealerships, in which leading software providers are accused of entering into an unlawful agreement, monopolizing access to auto sales and service data in dealer management software. Milberg attorneys achieved a $29.5 million settlement against one defendant and the case is proceeding against the remaining defendant. -
See More$106 Million Settlement – Daedalus, LLC v. City of Charlotte
Daedalus, LLC v. City of Charlotte, Mecklenburg Co. File No. 18-CVS-21073 (NC)$106 million class settlement on behalf of developers and home builders for illegally charged water and sewer capacity fees. -
See More$3.4 Billion Settlement – Avandia Marketing, Sales Practices, and Products Liability Litigation
In re Avandia Marketing, Sales Practices, and Products Liability Litigation, MDL 1871 (U.S. District Court for the Eastern District of Pennsylvania)Milberg attorneys were appointed to the Plaintiffs Steering Committee and served on the Discovery and Media Sub-Committees on behalf of thousands of patients who took the Type 2 diabetes drug Avandia, alleging the manufacturer failed to disclose the known and increased risk of heart attack and cardiac death. GlaxoSmithKline set aside $3.4 billion in 2011 to settle lawsuits. -
See More$54 Million Settlement – Miller v. CareCore National LLC
U.S. ex rel. Miller v. CareCore National LLC et al., No. 13-1177 (S.D.N.Y)Milberg, along with Co-Counsel, represented a whistleblower or “relator” in a false claims act case against CareCore, a company that provides benefit management services to Medicare Advantage and Medicaid Managed Care Organizations. The relator alleged that CareCore violated the False Claims Act by approving “prior authorizations” for expensive diagnostic procedures (such as MRIs) without reviewing them for medical necessity, as required. The Government intervened and the case settled in May 2017 for $54 million and the relator’s share of the settlement was $10.5 million.
